• Login
    • University Home
    • Library Home
    • Lib Catalogue
    • Advance Search
    View Item 
    •   IR@KDU Home
    • INTERNATIONAL RESEARCH CONFERENCE ARTICLES (KDU IRC)
    • 2021 IRC Abstracts
    • Allied Health Sciences
    • View Item
    •   IR@KDU Home
    • INTERNATIONAL RESEARCH CONFERENCE ARTICLES (KDU IRC)
    • 2021 IRC Abstracts
    • Allied Health Sciences
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Quality and In vitro Equivalence Testing of Chloroquine Phosphate 250 mg USP Tablets in Sri Lanka

    Thumbnail
    View/Open
    Allied-Health-Sciences E - Copy-50.pdf (512.1Kb)
    Date
    2021
    Author
    Madahasa, RHMPD
    Wijeratne, SMSR
    Undugoda, UPGS
    Nelumdeniya, NRM
    Fernandopulle, BMR
    Metadata
    Show full item record
    Abstract
    Exceptionally high quoted unit prices of antimalarials and the non-availability of World Health Organization (WHO) pre-qualified registered suppliers were two main challenges in procuring antimalarials in Sri Lanka. As such, having bioequivalence/ biowaiver studies to ensure the therapeutic performance of generics is of paramount importance since they can reduce the annual health expenditure associated. The objective of this study was to ensure the interchangeability of the generic chloroquine tablets produced locally by the State Pharmaceutical Manufacturing Corporation (SPMC) with a WHO prequalified product. Chloroquine is classified as eligible for biowaiver by the WHO based on its Biopharmaceutical Classification (BCS). Randomly selected three batches of generic tablets manufactured by SPMC and a batch of prequalified Chloroquine phosphate 250 mg from Anti-Malarial Campaign (AMC) Sri Lanka were tested for quality and comparative dissolutions according to the United States Pharmacopeia (USP) specifications. All four batches passed the weight variation, friability, disintegration, dissolution, and assay as per the specifications of USP, but the hardness test was passed only by the WHO prequalified product. In the comparison of dissolution test results, the locally produced generic product showed the highest standard of quality plus invitro equivalence that supported biowaiver conditions. The study confirmed that the SPMC chloroquine is of good quality and is equivalent to the reference product and hence interchangeable with the current Chloroquine Phosphate tablets used by the AMC.
    URI
    http://ir.kdu.ac.lk/handle/345/4727
    Collections
    • Allied Health Sciences [68]

    Library copyright © 2017  General Sir John Kotelawala Defence University, Sri Lanka
    Contact Us | Send Feedback
     

     

    Browse

    All of IR@KDUCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsFacultyDocument TypeThis CollectionBy Issue DateAuthorsTitlesSubjectsFacultyDocument Type

    My Account

    LoginRegister

    Library copyright © 2017  General Sir John Kotelawala Defence University, Sri Lanka
    Contact Us | Send Feedback